Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Rev Gastroenterol Mex ; 75(1): 97-102, 2010.
Artigo em Espanhol | MEDLINE | ID: mdl-20423790

RESUMO

Eosinophilic cholecystitis is a rare disease with clinical presentation similar to acute cholecystitis. The diagnosis is based on typical symptoms of acute cholecystitis with presence of more than 90% eosinophilic infiltration within the gallbladder wall. The case of a 27-year-old woman with periodic epigastric pain during ten years is presented. Routine and Boyden s technique biliary ultrasounds were normal. Hepatobiliary scintigraphy showed delayed gallbladder empty and patient underwent endoscopic sphinterotomy. Laparoscopic cholecystectomy was performed with uneventful postoperative course. Histopathologic examination of the gallblader demonstrated infiltration with eosinophils, consistent with acute eosinophilic cholecystitis.


Assuntos
Colecistite , Eosinofilia , Adulto , Colecistite/diagnóstico , Colecistite/cirurgia , Eosinofilia/diagnóstico , Eosinofilia/cirurgia , Feminino , Humanos
2.
Braz J Infect Dis ; 5(4): 223-32, 2001 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-11712967

RESUMO

Immunotherapy has been proposed as a method to treat mucosal leishmaniasis for many years, but the approach has been hampered by poor definition and variability of antigens used, and results have been inconclusive. We report here a case of antimonial-refractory mucosal leishmaniasis in a 45 year old male who was treated with three single injections (one per month) with a cocktail of four Leishmania recombinant antigens selected after documented hypo-responsiveness of the patient to these antigens, plus 50 microg of GM-CSF as vaccine adjuvant. Three months after treatment, all lesions had resolved completely and the patient remains without relapse after two years. Side effects of the treatment included only moderate erythema and induration at the injection site after the second and third injections. We conclude that carefully selected microbial antigens and cytokine adjuvant can be successful as immunotherapy for patients with antimonial-refractory mucosal leishmaniasis.


Assuntos
Antígenos de Protozoários/uso terapêutico , Fator Estimulador de Colônias de Granulócitos e Macrófagos/uso terapêutico , Imunoterapia , Úlcera da Perna/tratamento farmacológico , Leishmania/imunologia , Leishmaniose Mucocutânea/tratamento farmacológico , Adjuvantes Imunológicos/uso terapêutico , Animais , Humanos , Leishmaniose Mucocutânea/patologia , Masculino , Pessoa de Meia-Idade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA